CIK 0000725363
- Non-accelerated filer
- Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- Operating
- EIN
- 840916344
- Phone
- +1 703-506-9460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- 4 Grant or award Senior Vice President acquired 309 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 205 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 335 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 366 shares (grant or award)
- 4 Open-market buy Director bought 100 shares at $14.24 ($1,424)
- 4 Open-market buy Director bought 800 shares at $11.68 ($9,343)
- 4 Open-market buy Director bought 800 shares at $11.77 ($9,416)
- 4 Open-market buy Director bought 800 shares at $11.77 ($9,416)
- 4 Open-market sale Senior Vice President sold 10,000 shares at $12.73 ($127,290)
- 4 Open-market buy Director bought 3,000 shares at an average $11.35 ($34,060)
- 4 Grant or award Senior Vice President acquired 275 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 188 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 297 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 335 shares (grant or award)
- 4 Grant or award Senior VP, Research acquired 228 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 160 shares (grant or award)
- 4 Grant or award Senior VP, Operations acquired 245 shares (grant or award)
- 4 Grant or award CEO acquired 286 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 41 · 806 filings